FindTrial
Sign In

Drug resistance in leprosy: A cross sectional comparative study

Drug resistance in reactional and non reactional leprosy: A cross-sectional comparative study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/069804
Enrollment
200
Registered
2024-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A309- Leprosy, unspecified

Interventions

Intervention1: Nil: This is an observational cross-sectional study Patient with drug resistant leprosy will be treated with alternative MB-MDT regimen according to WHO Control Intervention1: Nil: nil

Sponsors

All India Institute Of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Reactional leprosy Any age Paucibacillary or multibacillary hansen with type 1/2 reaction Definite past history of reaction in last 6 months Non reactional leprosy

Exclusion criteria

Exclusion criteria: i. Pure neural hansen ii. doubtful past history of reaction iii. Adequately treated hansen with no treatment required

Design outcomes

Primary

MeasureTime frame
Prevalence of drug resistance in reactional versus non-reactional leprosy Timepoint: 2 Years—

Secondary

MeasureTime frame
Clinical outcomes of alternative antileprosy treatment in reactional and non reactional leprosy Clinical and microbiological difference between reactional and non-reactional leprosy Compare rates of drug resistance among new, defaulters and relapse leprosy casesTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Vishal Gupta

ALL INDIA INSTITUTE OF MEDICALSCIENCES

doctor.vishalgupta@gmail.com0112658850

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026